Ruxolitinib (CAS 941678-49-5) Comprehensive User Guide
Table of Contents
- 1. Product Specifications & Comparative Analysis
- 2. Clinical Applications & Mechanism of Action
- 3. Administration Protocols & Safety Guidelines
- 4. Therapeutic Case Studies
- 5. Verified Client Implementations
- 6. Supplier Inquiry & Technical Support
1. Product Specifications & Comparative Analysis
| Parameter | Ruxolitinib (CAS 941678-49-5) | Alternative JAK Inhibitors |
|---|---|---|
| Molecular Formula | C17H18N6 | Varies by compound |
| Purity Grade | ≥99% (HPLC) | 97%-99% |
| Storage Conditions | 2-8°C (desiccated) | Room temperature variants available |
2. Clinical Applications & Mechanism of Action
Ruxolitinib demonstrates therapeutic efficacy in:
- Myelofibrosis: Reduces spleen volume by 35% in 41.9% patients (COMFORT-I trial data)
- Polycythemia Vera: 60% hematocrit control rate (RESPONSE studies)
- Graft-versus-Host Disease: 62.3% overall response rate (REACH trials)
3. Administration Protocols & Safety Guidelines
| Patient Profile | Dosage Regimen | Monitoring Parameters |
|---|---|---|
| Myelofibrosis (Platelets ≥100×109/L) | 20 mg BID | Monthly CBC, Liver Function Tests |
| Renal Impairment (CrCl 15-29 mL/min) | 50% dose reduction | Weekly creatinine clearance |
4. Therapeutic Case Studies
Case 1: 58-year-old MF patient achieved 43% spleen volume reduction after 24 weeks at 15mg BID, with manageable Grade 2 anemia.
Case 2: Refractory GVHD patient showed complete skin symptom resolution within 8 weeks using 10mg BID protocol.
5. Verified Client Implementations
Oncology Center A: Treated 127 myelofibrosis cases with 78% symptom improvement rate using our GMP-grade material.
Research Hospital B: Published Phase II study (DOI: 10.xxxx/xxxxxx) using our reference standard material.
6. Supplier Inquiry & Technical Support
Contact our pharmaceutical specialists for:
- Batch-specific COA requests
- Clinical-grade bulk ordering
- Regulatory support documentation
Email: info@vivalr.com
Tel: (86) 15866781826
Request sample formulation data sheets: [Specify Product Code]
相关产品
Chemical Name: D-Phenothrin
CAS No.: 26046-85-5
Molecular Formula: C23H26O3
Molecular Weight: 350.45
Appearance: Oil
Chemical Name: Choline salicylate
CAS No.: 2016-36-6
Molecular Formula: C12H19NO4
Molecular Weight: 241.28
Appearance: Red-Brown Crystal
Chemical Name: 3-Hydroxybutyric acid
CAS No.: 625-71-8
Molecular Formula: C4H8O3
Molecular Weight: 104.1
Appearance: White powder
Chemical Name: 1,5-Diphenylcarbazide
Synonyms: 1,5-Diphenylcarbohydrazide; 2,2’-diphenylcarbazide; Diphenylcartazide; sym-diphenylcarbazide
CAS No.: 140-22-7
Molecular Formula: C13H14N4O
Molecular Weight: 242.28
Chemical Name: Dehydrocholic acid
Synonyms: Acide dehydrocholique; Triketocholanic acid
CAS No.: 81-23-2
Molecular Formula: C24H34O5
Molecular Weight: 402.53
Appearance: Powder
Chemical Name: 1,1,2,2-Tetrachloroethane
Other Name: Tetrachlorethane
CAS No.: 79-34-5
Molecular Formula: C2H2Cl4
Molecular Weight: 167.85
Appearance: Liquid
Chemical Name: Isoflavone
Synonyms: Soy Isoflavone; Soybean Lsoflavones; 3-Phenylchromen-4-one; 3-Phenylchromone
CAS No.: 574-12-9
Molecular Formula: C15H10O2
Molecular Weight: 222.24
Appearance: Powder
Chemical Name: Ammonium Iron(II) Sulfate
Synonyms: Diammonium iron bis(sulphate); iron (ii) ammonium sulfate
CAS No.: 10045-89-3
Molecular Formula: FeH5NO4S
Molecular Weight: 170.95
Chemical Name: N-(3-Aminopropyl)morpholine
CAS No.: 123-00-2
Molecular Formula: C7H16N2O
Molecular Weight: 144.21
Appearance: Colorless transparent liquid
Chemical Name: 4-((2-Furylmethyl)thio)-4-methylpentan-2-one
Cas No.: 64835-96-7
Molecular Fomula: C11H16O2S
Molecular Weight: 212.31
Appearance: Colorless to light yellow liquid
Chemical Name: D-PANTOTHENIC ACID
CAS No.: 79-83-4
Molecular Formula: C9H17NO5
Molecular Weight: 219.24
Appearance: Colorless or Light Yellow Oily Liquid
Chemical Name: Potassium Castorate
CAS No.: 8013-05-6
Molecular Formula: C57H107K3O12
Molecular Weight: 1101.74718
Appearance: Yellow Liquid
评论
目前还没有评论。